Overview

Drug discovery aims to find and develop molecules that act on disease-relevant targets or biological processes, while balancing efficacy, safety, and the ability to make them. AI methods include graph and 3D models for predicting molecular properties, binding, and toxicity; generative models for proposing or editing molecules; and knowledge graphs and omics models for prioritizing targets and interpreting biological responses. Search and design methods increasingly combine these predictions with docking, synthesis constraints, experimental data, and tools coordinated by AI agents. A central challenge is that strong results on standard benchmarks may not transfer to unseen targets, chemistry, or assays, and computational scores still need reliable experimental validation.

Latest papers

CardsList

178 papers15 papers in the last four weeks, down 37% on the four weeks before. 0.1% of all new papers.

  1. Reasoning in the loop: antibody lead optimization by probing mechanism and measurement

    Nov 15, 2026Samuel Stanton, Aaron Solomon, Emily Delaney +7Drug Discoveryantibody design

  2. CupOFMoCA: Coupled Objective-Guided Discrete Flows for Molecular Conjugate Assembly

    Nov 11, 2026Ruoxi Rosie Zhang, Ziang Li, Jiatao Gu +1Molecular GenerationDrug Discovery

  3. The Dose Makes the Poison: Exposure-Aware Evaluation of Generative Drug Design

    Nov 10, 2026Maria Franz, N. Benjamin Erichsonpharmacokinetic modelingDrug Discovery

  4. El Agente Fármaco: A Scalable AI Scientist for Drug Discovery

    Nov 2, 2026Marcel Müller, Mohammad Ghazi Vakili, Yoshihiro Ogura +13Drug DiscoveryScientific Workflow Automation

  5. Can agents reliably design therapeutic antibodies?

    Oct 31, 2026Asli Alpman, Nick Bhattacharya, Aaron Solomon +1Tool-Using AgentsLLM Agent Reliability

  6. DELBERT-2: Pretrained Fingerprint Language Models for DEL Protein Binder Prediction

    Oct 30, 2026Bing Hu, Sun Sun, Shaik Salman Basha +2Drug DiscoveryMolecular Foundation Models

  7. Transferring Peptide-Target Interaction Patterns to Small Molecules by Joint Guidance for Diffusion and Flow Matching

    Oct 30, 2026Jian Lee, Changyun Cho, Sun Kim3D Molecular GenerationDrug Discovery

  8. D2ML: Models for Direct-to-Biology Small Molecule Screening

    Oct 29, 2026AkshatKumar Nigam, Neri Amara, Hillary Dequina +7Drug DiscoveryMolecular Property Prediction

  9. MoLRSI: A Recursive Self-Improving AI agent for Molecular Discovery

    Oct 29, 2026Yikun Zhang, Xiwei Cheng, Mingze Yuan +15Self-Improving AgentsScientific Workflow Automation

  10. Computational De Novo Design of Miniprotein Candidate Neutralizers Targeting the IL-23 Cytokine Subunit p19

    Oct 23, 2026Raghav Paladugu, Fardina Fathmiul AlamProtein Binder DesignProtein Design

  11. A curated multi-endpoint drug-protein bioactivity dataset with construct-aware protein targets

    Oct 23, 2026Lina Abou-Abbas, Nour Mhanna, Hasan Bazzi +4Drug DiscoveryProtein-Ligand Binding Affinity Prediction

  12. HierDTA: Hierarchical Structure-Aware Representation Learning for Drug--Target Affinity Prediction

    Oct 19, 2026Huangchao Xu, Baohua Zhang, Qian Liu +2Protein-Ligand Binding Affinity PredictionDrug Discovery

  13. Generative Retrieval for Reverse Target Fishing with a Proteome-Scale Benchmark

    Oct 17, 2026Zhichao Deng, Haichuan Tan, Xin Hong +4Drug DiscoveryGenerative Retrieval

  14. On the Selectivity of Generative Models in Structure-Based Drug Design

    Oct 16, 2026Ella Miray Rajaonson, Jungyoon Lee, William Chau +5Structure-Based Drug DesignDrug Discovery

  15. DrugHarness: An Evolvable Agent Harness for Computational Drug Discovery

    Oct 16, 2026Yuxing Chen, Zhisheng Zhang, Cheng Tang +20LLM Agent HarnessesDrug Discovery

  16. Beyond Fixed Acquisition Functions: Temporal Difference Active Learning for Perturbation Discovery

    Oct 15, 2026Xudong Zhang, Jianzhe Li, Yitong Tang +1Active LearningAdaptive Sampling

  17. MolHop: Scaffold-Hopping Molecular Design with Agentic Reinforcement Learning

    Oct 14, 2026Yanyi Su, Chenyan Wang, Yulei Gong +3Molecule DesignMolecular Generation

  18. PairIT: Autoregressive Transformers for Low-Data Molecule Optimization

    Oct 13, 2026Hannah Lawrence, Bodhi P. Vani, Ji Won Park +5Autoregressive TransformerMolecular Optimization

  19. zPocket: Better Pocket Finding with Frozen Co-Folding Features

    Oct 13, 2026Tally Portnoi, Allison M Keys, Benjamin R DiFrancesco +1Drug DiscoveryStructure-Based Drug Design

  20. MADDIE: Multi-Agent Drug Discovery Engine

    Oct 12, 2026Ye Liu, Reza Averly, Avery Meyer +4Drug DiscoveryMulti-Agent LLM Systems

  21. FragFlex: Fragment-Based Flexible Molecular Generation for Exploring Vast Chemical Space

    Oct 11, 2026Sihyun Park, David Ryan KoesMolecular Graph GenerationMolecular Generation

  22. Cross-species representation learning aligns mouse and human neural dynamics and tracks clinical drug efficacy

    Oct 8, 2026Marko Tvrdic, Justin Richmond Domingo, Jae Ann Buenaluz +4Representation LearningContrastive Learning

  23. CircuitATLAS: Agentic reasoning over a systems neuroscience knowledge graph for target discovery in circuitopathies

    Oct 7, 2026Gabriel Ocana-Santero, Marko TvrdicDrug DiscoveryBiomedical KGs

  24. DrugTargetWorld: A Synthetic Biobank for Training and Benchmarking AI Scientists

    Oct 7, 2026Samuel Margolis, Paul Schmiedmayer, Alan Huang +12Drug DiscoveryAI Agent Benchmarks

  25. Information-Dense Synthesis for Molecular Discovery

    Oct 6, 2026Kasper K. Jakobsen, Eli N. WeinsteinMolecular OptimizationDrug Discovery

  26. Can phenotypic activity be predicted without experimental readouts?

    Oct 6, 2026Télio Cropsal, Rocío MercadoMolecular Property PredictionMolecular Representation Learning

  27. From Benchmark to Bench: Can Agents Survive Real-World Drug Discovery?

    Oct 5, 2026Pierre Llompart, Levent Guner, Helen Lai +2AI Agents for Scientific DiscoveryLLM Agent Orchestration